The human 25-hydroxyvitamin D 3 (25(OH)D 3 ) 1a-hydroxylase, which is encoded by the CYP27B1 gene, catalyzes the metabolic activation of the 25(OH)D 3 into 1a,25-dihydroxyvitamin D 3 (1a,25(OH) 2 D 3 ), the most biologically potent vitamin D 3 metabolite. The most important regulator of CYP27B1 gene activity is 1a,25(OH) 2 D 3 itself, which down-regulates the gene. The down-regulation of the CYP27B1 gene has been proposed to involve a negative vitamin D response element (nVDRE) that is located $500 bp upstream from transcription start site (TSS). In this study, we reveal the existence of two new VDR-binding regions in the distal promoter, 2.6 and 3.2 kb upstream from the TSS, that bind vitamin D receptor-retinoid X receptor complexes. Since the down regulation of the CYP27B1 gene is tissue-and cell-type selective, a comparative study was done for the new 1a,25(OH) 2 D 3 -responsive regions in HEK-293 human embryonic kidney and MCF-7 human breast cancer cells that reflect tissues that, respectively, are permissive and nonpermissive to the phenomenon of 1a,25(OH) 2 D 3 -mediated down-regulation of this gene. We found significant differences in the composition of protein complexes associated with these CYP27B1 promoter regions in the different cell lines, some of which reflect the capability of transcriptional repression of the CYP27B1 gene in these different cells. In addition, chromatin architecture differed with respect to chromatin looping in the two cell lines, as the new distal regions were differentially connected with the proximal promoter. This data explains, in part, why the human CYP27B1 gene is repressed in HEK-293 but not in MCF-7 cells.
INTRODUCTION
The biologically active form of vitamin D, 1a, 25-dihydroxyvitamin D 3 (1a,25(OH) 2 D 3 )), is required for mineral homeostasis and skeletal integrity, as well as controlling cell growth and differentiation in several tissues (1) . In the body, the amount of 1a,25(OH) 2 D 3 is tightly controlled by several enzymes that are transcribed from genes belonging to the cytochrome P450 (CYP) family. This gene family encodes a wide variety of enzymes that are needed in the oxidative metabolism of a number of endogenous and exogenous compounds (2) . One of the enzymes needed in the metabolism of 1a,25(OH) 2 (3) . CYP27B1 gene expression is negatively regulated by 1a,25(OH) 2 D 3 , and this has been proposed to occur via a negative vitamin D response element (nVDRE), located $500 bp upstream from transcription start site (TSS) (4) . The down-regulation of this gene by 1a,25(OH) 2 D 3 is a cell-type and tissue-restricted phenomenon. In the body, the major expression site of the CYP27B1 gene and its protein product, 25(OH)D 3 1a-hydroxylase (CYP27B1), is the kidney. Within this organ, both the mRNA and the protein product have been observed to be repressed in the presence of 1a,25(OH) 2 D 3 in the proximal tubules only (5) . The CYP27B1 gene is also expressed in extra renal sites (6) , however the suppression of the gene by 1a,25(OH) 2 D 3 has been described only in a few other cell lines derived from other tissues, such as colon-derived cells (7) .
The effects of 1a,25(OH) 2 D 3 are mediated via the vitamin D receptor (VDR), a member of the nuclear receptor superfamily, to which 1a,25(OH) 2 D 3 binds with high affinity. Responsiveness of a given gene to 1a,25(OH) 2 D 3 requires that its regulatory regions contain a VDRE. The VDREs of positively regulated genes are direct repeats of two hexameric-core-binding motifs spaced by 3 or 4 nt (DR3 or DR4, respectively) or everted repeats spaced by 6-9 nt (ER6 and ER9, respectively) (8, 9) . The hexameric sequences of the response elements of the primary 1a,25(OH) 2 D 3 target genes usually have the consensus sequence RGKTSA (R ¼ A or G, K ¼ G or T, S ¼ C or G). The VDREs of most previously studied negatively regulated genes resemble those of positively regulated genes, although negative regulation may not necessarily require both VDRE half sites (10) (11) (12) . The reported negative VDRE of the CYP27B1 is an exception, because it does not contain a consensus sequence (4) . In addition, the authors proposed that the regulation of the CYP27B1 gene involves an indirect binding of VDR to DNA, where VDR associates with the nVDRE liganddependently via another transcription factor, the VDR interacting repressor (VDIR).
Binding of 1a,25(OH) 2 D 3 causes a conformational change within the ligand-binding domain of the VDR, which modulates its interactions with nuclear proteins, such as coactivator (CoA) and corepressor (CoR) proteins (13) . CoR proteins, such as NCoR1 (14) and SMRT/ NCoR2 (15) , link non-liganded, DNA-bound VDR to enzymes with histone deacetylase activity that cause chromatin condensation (16) . The conformational change within VDR's ligand-binding domain results in the replacement of a CoR by a CoA protein of the p160 family, such as SRC-1, SRC-2 or SRC-3 (17) . These CoAs link the ligand-activated VDR to enzymes displaying histone acetyltransferase (HAT) activity, such as CBP, that cause chromatin relaxation by their action on histone tails and thereby reversing the action of unliganded VDR (18) .
Traditionally, VDREs are thought to locate relatively close to the TSS of 1a,25(OH) 2 D 3 target genes. For example, both human and rat vitamin D 24-hydroxylase (CYP24) genes have a cluster of VDREs in their proximal promoters (approximate position À140 to À300) (19) (20) (21) (22) . However, recently several promoter studies have revealed that the gene promoters may contain multiple response elements that locate not only within proximal promoters but also in more distal regions (23, 24) and even within coding regions (25, 26) . These studies have so far concerned with only positively regulated genes. This raises a question, whether negatively regulated genes also have multiple response elements. Since the promoter studies of the human CYP27B1 gene have so far been limited to the first 1.7 kb upstream of the TSS (4, (27) (28) (29) , in this study, we have extended the promoter analysis further upstream and examined the role of distal promoter regions to the regulation of the human CYP27B1 gene by 1a,25(OH) 2 D 3 . We analyzed 13 contiguous genomic regions spanning 5.4 kb of the CYP27B1 promoter by chromatin immunoprecipitation (ChIP) scanning. Our studies revealed two new 1a,25(OH) 2 D 3 -responsive regions in the distal promoter 2.6 and 3.2 kb upstream from the TSS. Interestingly, in contrast to the nVDREcontaining region, in silico screening revealed that both of the new 1a,25(OH) 2 D 3 -responsive regions contained classical VDRE sequences that were shown to directly bind VDR-retinoid X receptor (RXR) heterodimers in a ligand-dependent manner, when studied by gel shift assays. Extensive ChIP analysis suggested that the new regions have a number of similarities with the established nVDRE in the recruitment of different cofactors, as well as recruiting both VDR and RXR, supporting the idea that the putative VDREs are functional. In addition, chromatin conformation capture (3C) analysis suggested that the new regions are directly connected with the TSS via chromatin looping in a ligand-dependent and cell-specific manner.
MATERIALS AND METHODS

Cell culture
HEK-293 human embryonic kidney cells and MCF-7 human breast cancer cells were maintained in Dulbecco's modified Eagle medium (DMEM) containing 5% fetal bovine serum (FBS), 2 mM L-glutamine, 0.1 mg/ml streptomycin and 100 U/ml penicillin in a humidified 95% air-5% CO 2 incubator. Before use in experimental procedures, FBS was stripped of lipophilic compounds, such as endogenous nuclear receptor ligands, by stirring it with 5% activated charcoal (Sigma-Aldrich, St. Louis, MO, USA) for 3 h at room temperature. Charcoal was then removed by centrifugation and the media was sterilized by filtration (0.2 mM pore size). Prior to mRNA or chromatin extraction, the cells were grown overnight in phenol red-free DMEM, supplemented with 5% charcoal-stripped FBS, to reach 50-60% confluency. For ChIP assays, the cells were first treated with 2.5 mM a-amanitin (Sigma-Aldrich) for 2 h, followed by exposure to the ligand, after the removal of the a-amanitin. The cells were then treated with either solvent (ethanol, 0.1% final concentration) or with the 10 nM 1a,25(OH) 2 D 3 (kindly provided by Dr Lise Binderup, LEO Pharma, Ballerup, Denmark, diluted in ethanol). For the RNAi analysis, the cells were grown in phenol red-free DMEM supplemented with 5% charcoal-stripped FBS until they reached a confluency of 40-50%.
Total RNA extraction, cDNA synthesis and real-time PCR Total RNA was extracted using the Mini RNA Isolation II kit (Zymo Research, HiSS Diagnostics, Freiburg, Germany) and cDNA synthesis was performed for 1 h at 378C using 1 mg of total RNA as a template, in the presence of 100 pmol oligodT 18 primer and 40 U reverse transcriptase (Fermentas, Vilnius, Lithuania). Realtime quantitative PCR was performed in an IQ-cycler (BioRad, Hercules, CA, USA) using the dye SybrGreen I (Molecular Probes, Leiden, The Netherlands). Per reaction, 0.3 U Hot Start Taq polymerase (Fermentas) and 3 mM MgCl 2 were used and the PCR cycling conditions were: 40 cycles of 30 s at 958C, 30 s at 628C and 40 s at 728C. The sequences of the gene-specific primer pairs for the human CYP24, CYP27B1, METTL1, VDIR and the reference gene RPLP0 are listed in Table 1 . PCR product quality was monitored using post-PCR melt curve analysis.
RNAi and immunoblotting
HEK-293 and MCF-7 cells were transfected with either non-specific siRNA oligomers or Stealth TM siRNAs targeting the VDR mRNA (Invitrogen, Carlsbad, CA, USA) by using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA) according to the instructions of the manufacturer. The cells were seeded into 6-well plates and grown in phenol red-free DMEM supplemented with 5% charcoal-stripped FBS. Liposomes containing control or VDR siRNA were formed by incubating 100 pmol of each siRNA duplex with 5 ml of Lipofectamine 2000 for 20 min at room temperature in a total volume of 500 ml of phenol red-free DMEM without antibiotics. The liposomes were added to the cells and siRNA treatment was continued for 72 h after which the cells were treated with ethanol or 10 nM 1a,25(OH) 2 D 3 for 3 h. Total RNA extraction, cDNA synthesis and the real time quantitative PCR analysis were done as mentioned above. Silencing of VDR at the protein level was verified by immunoblotting using 25 mg of whole cell extract from HEK-293 or MCF-7 cells and anti-VDR antibody (sc-1008, Santa Cruz Biotechnologies, Heidelberg, Germany). Cellular proteins were separated using 12% SDS polyacrylamide gel electrophoresis. The blotted proteins were detected by using ECF Western Blotting kit according to the manufacturer's guidelines (GE Healthcare Europe, Helsinki, Finland).
DNA constructs
Full-length cDNAs for human VDR (30) and human RXRa (31) were subcloned into the T 7 /SV40 promoterdriven pSG5 expression vector (Stratagene, LaJolla, CA, USA). The same constructs were used for both T 7 RNA polymerase-driven in vitro transcription/translation of the respective cDNAs and for viral promoter-driven overexpression in mammalian cells. Promoter regions of the CYP27B1 gene (see Figure 4) were cloned by PCR from human genomic DNA using Pfu DNA polymerase (Fermentas, Vilnius, Lithuania) and were fused with the thymidine kinase (tk) promoter driving the firefly luciferase (Luc) reporter gene. All constructs were verified by sequencing.
Gel shift analysis
VDR, RXR and VDIR proteins were generated by coupled in vitro transcription/translation using their respective pSG5-based cDNA expression constructs and TNT Quick Coupled Transcription/Translation Systems as recommended by the supplier (Promega, Madison, WI, USA). Protein batches were quantified by test translation in the presence of 35 S-methionine (see Figure 3B ). The specific concentration of the receptor proteins was adjusted to $4 ng/ml (10 ng corresponds to $0.2 pmol) after taking the individual number of methionine residues per protein into account. Gel shift assays were performed with 10 ng of the appropriate in vitro-translated proteins. The proteins were incubated for 15 min in a total volume of 20 ml of binding buffer (10 mM Hepes (pH 7.9), 150 mM KCl, 1 mM dithiothreitol, 0.2 mg/ml of poly(dI-C), 5% glycerol). Constant amounts (1 ng) of 32 P-labeled doublestranded oligonucleotides (50 000 c.p.m.) corresponding to one copy of dimeric response element were then added and incubation was continued at room temperature for 20 min. Protein-DNA complexes were resolved by electrophoresis through non-denaturing 8% (w/v) polyacrylamide gels in 0.5Â TBE (45 mM Tris, 45 mM boric acid, 1 mM EDTA, pH 8.3) and quantified on an FLA-3000 reader (Fuji, Tokyo, Japan) using Image Gauge software (Fuji, Tokyo, Japan). Oligonucleotides were labeled by a Klenow fragment DNA polymerase (Fermentas, Vilnius, Lithuania)-mediated filling in reaction in the presence of a nucleotide mixture containing radiolabeled 32 P a-dCTP.
ChIP assays
ChIP assays were performed as previously described (24 The PCR products were separated by electrophoresis through 2% agarose gels. Gel images were scanned on an FLA-3000 reader (Fuji, Tokyo, Japan) and analyzed using Image Gauge software (Fuji, Tokyo, Japan).
3C analysis
Prior to 3C analysis, the ligand treatment, formaldehyde crosslinking and collection of the HEK-293 and MCF-7 
0 cells were done as described for the ChIP analysis. After harvesting of the cells by centrifugation, the cell pellets were resuspended in 3C lysis buffer 1 (5 mM PIPES, pH 8.0, 85 mM KCl, 0.5% NP-40, protease inhibitors) and the nuclei were collected by centrifugation and washed once with ice-cold PBS. The pellets were resuspended in 3C lysis buffer 2 (1Â PBS, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, protease inhibitors). Cellular debris was removed by centrifugation and the lysates were divided into 200 ml aliquots. The aliquots were diluted by adding 150 ml of sterile water and 40 ml of 10Â digestion buffer (50 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 100 mM NaCl, 0.1 mg/ml BSA) and 100 U of HinfI restriction enzyme (Fermentas). The samples were incubated overnight at 378C after which 50 U of T4 DNA ligase (Fermentas) and rATP (final concentration of 0.5 mM, Fermentas) were added. The samples were incubated for 1 h at room temperature and then 2 ml of proteinase K (10 mg/ml, Fermentas) was added and the samples were further incubated overnight at 648C. Finally, the DNA was recovered by phenol-chloroform extraction followed by ethanol precipitation and analyzed by PCR using primers which are listed in Table 3 .
Cell transfections and luciferase reporter gene assays
HEK-293 and MCF-7 cells were seeded into 6-well plates (10 5 cells/ml) and grown overnight in phenol red-free DMEM supplemented with 5% charcoal-stripped FBS. Plasmid DNA containing liposomes were formed by incubating a reporter plasmid and the expression vector for human VDR (each 1 mg) with 10 mg N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulfate (DOTAP, Roth, Karlsruhe, Germany) for 15 min at room temperature in a total volume of 100 ml. After dilution with 900 ml phenol red-free DMEM, the liposomes were added to the cells. Here, 500 ml of phenol redfree DMEM supplemented with 15% charcoal-stripped FBS was added 4 h after transfection. At this time, either 100 nM 1a,25(OH) 2 D 3 or solvent was also added. The cells were lysed, 16 h after onset of stimulation, using reporter gene lysis buffer (Roche Diagnostics, Mannheim, Germany). The constant light signal luciferase reporter gene assay was performed as recommended by the supplier (Canberra-Packard, Groningen, The Netherlands). Luciferase activities were normalized with respect to protein concentration and induction factors were calculated as the ratio of luciferase activity of ligand-stimulated cells to that of solvent controls.
RESULTS
Expression profiling of CYP27B1 gene expression in response to 1a,25(OH) 2 D 3
To establish model systems, in which to study the expression level and the transcriptional responsiveness of the CYP27B1 gene, we have chosen the cell line HEK-293, which was derived from a tissue (kidney) where this gene is known to be regulated by 1a,25(OH) 2 D 3 . As a reference, we took the cell line MCF-7, which is often used to study 1a,25(OH) 2 D 3 signaling, but in which the CYP27B1 gene is not regulated by 1a,25(OH) 2 D 3 . The expression of the CYP27B1 gene and its response to 1a,25(OH) 2 D 3 was studied by real-time quantitative PCR ( Figure 1A ). As a control, the methyltransferase-like-1 (METTL1) gene, a direct genomic neighbor of the CYP27B1 gene, was studied in case the hormone also regulated its transcription. Moreover, the levels of the VDIR gene were examined, because of its key role in the regulation of CYP27B1 gene (4) . Finally, the CYP24 gene, which is known to be strongly up-regulated in the presence of 1a,25(OH) 2 D 3 , was used as a positive control for the presence of the hormone. In HEK-293 cells, the CYP27B1 mRNA expression was significantly down-regulated after 6 and 24 h treatment with 1a,25(OH) 2 D 3 . In contrast, in MCF-7 cells, CYP27B1 mRNA expression was not affected by 1a,25(OH) 2 D 3 treatment. This non-responsive effect of MCF-7 cells has already been observed before (32) . The expression of METTL1 mRNA did not change in MCF-7 cells but in HEK-293 cells a transient down 
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regulation at 6 h could be observed. VDIR mRNA expression followed the METTL1 expression in both cell lines. CYP24 mRNA expression was significantly induced in both cell types. In order to confirm the dependence of the regulation of the genes by 1a,25(OH) 2 D 3 on VDR expression, VDR mRNA levels were inhibited by using specific siRNA oligomers ( Figure 1B-C) . Quantitative real-time PCR analysis showed that siVDR treatment significantly increased CYP27B1 mRNA expression in HEK-293 cells but had no effect in MCF-7. For the expression of both the METTL1 and the VDIR genes, no significant differences between control siRNA and VDR siRNAtreated cells could be observed, indicating that the changes in their mRNA expression ( Figure 1A ) are probably not caused by 1a,25(OH) 2 D 3 treatment. When unspecific siRNA was used, 1a,25(OH) 2 D 3 was able to up-regulate CYP24 mRNA expression 3.5-fold in HEK-293 cells and 4000-fold in MCF-7 cells. However, when VDR siRNA was used, CYP24 mRNA expression stayed at basal levels in HEK-293 cells and in MCF-7 an 80% decreased ligand effect was observed. Taken together, the analysis of the CYP24 gene expression confirms that both HEK-293 and MCF-7 cells have functional VDR-dependent 1a,25(OH) 2 D 3 signaling. However, only in the kidney-derived HEK-293 cells, the CYP27B1 gene is down-regulated by 1a,25(OH) 2 D 3 via the VDR. Finally, the genes METTL1 and VDIR appear not to be primary targets of the VDR.
Scanning the CYP27B1 promoter for VDR-binding sites
We scanned in silico the first 5.2 kb of the human CYP27B1 promoter for putative VDREs utilizing the Internet portal NUBIScan (www.nubiscan.unibas.ch) (33) (Figure 2A ). This screening revealed seven DR3-type and two DR4-type VDREs (Figure 2A) . Interestingly, only one DR3-type VDRE was found within the first 1.7 kb of the promoter, to which previous studies were restricted (4, (27) (28) (29) . This region could be considered as the 'pure' promoter of the CYP27B1 gene, since the METTL1 gene is located only 1.2-5.4 kb upstream from its TSS. Thus, the eight other putative DR3-and DR4-type VDREs are located within METTL1 gene.
Next we used chromatin from crosslinked 1a,25(OH) 2 D 3 -treated HEK-293 and MCF-7 cells, precipitated it with anti-VDR antibody and used the eluted chromatin template for a scanning with 13 overlapping genomic PCR primer pairs covering these 5.4 kb of the human CYP27B1 promoter ( Figure 2B and C) . We observed VDR binding to the region of the established nVDRE (region 2: À350 to À776) but also to two additional regions located further upstream (region 7: À2486 to À2885 and region 9: À3070 to À3462). All three regions recruited VDR in a ligand-dependent fashion, reaching a maximum 120 min after onset of ligand treatment. Interestingly, three of the putative DR3-type VDREs lay within VDR-binding regions (Figure 2A ). In summary, in living HEK-293 and MCF-7 cells, VDR binds to three regions within the first 5.4 kb of the human CYP27B1 promoter. The proximal region 2 contains the nVDRE, while the two distal regions 7 and 9 are located within the METTL gene and carry classical DR3-type VDREs.
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Distal VDREs in the CYP27B1 promoter show direct VDR binding
The potential of the nVDRE of region 2, VDRE1 of region 7 and VDREs 2 and 3 of region 9 (for sequence, see Figure 3A ) to associate with in vitro-translated VDR, RXR and VDIR ( Figure 3B ) were compared by gel shift analysis. The established DR4-type VDRE of the rat Pit-1 gene (34) served as a positive control ( Figure 3C ). None of the four classical VDREs bound VDR or RXR alone, but with the exception of VDRE3 they bound, in a liganddependent fashion, VDR-RXR heterodimers (Figure 3C , E-G). VDIR bound efficiently to the nVDRE ( Figure 3D ), but did not interfere with the ligand-dependent VDR-RXR heterodimer formation on VDRE1, VDRE2 and the positive control ( Figure 3C , E and F). Conversely, VDR and RXR did not associate on the nVDRE and did not interfere with VDIR binding to this element, either as monomers or as heterodimers ( Figure 3D) . Similarly, an anti-VDR antibody could not modulate the binding of VDIR on the nVDRE ( Figure 3D ), but it reduced the binding of VDR-RXR heterodimers to VDRE1, VDRE2 and the positive control ( Figure 3C, E and F) .
Taken together, in vitro, the nVDRE shows only association with VDIR protein, while VDRE1 and VDRE2 binds only VDR-RXR heterodimers. VDRE3 does not bind any of these proteins, suggesting that the binding of VDR to region 9 is mediated by VDRE2.
The ability of isolated CYP27B1 promoter regions to repress transcription
The functionality of the genomic regions 2, 7 and 9 of the human CYP27B1 promoter was examined alone or together in a large promoter fragment by reporter gene assays in HEK-293 and MCF-7 cells (Figure 4) . As a positive control, we used the proximal promoter of the human CYP24 gene that contains a cluster of DR3-type VDREs. The latter promoter fragment was 6-fold inducible by 1a,25(OH) 2 D 3 in HEK-293 cells and showed even a 30-fold inducibility in MCF-7 cells. In HEK-293 cells the basal activity of regions 2, 7 and 9 of the CYP27B1 promoter was reduced by 15-40% by 1a,25(OH) 2 D 3 treatment, but only the reductions of regions 2 and 9 were found to be statistically significant ( Figure 4A) . The large CYP27B1 promoter fragment containing all three regions was even 450% reduced. In contrast, in MCF-7 cells, none of the four CYP27B1 promoter constructs showed any significant response to stimulation with 1a,25(OH) 2 D 3 ( Figure 4B ).
In summary, this analysis of the activity of the CYP27B1 promoter parallels to the observation made on the level of mRNA expression (Figure 1 ), in that only in HEK-293 cells but not in MCF-7 cells, can a downregulation by 1a,25(OH) 2 D 3 be found. Interestingly, not only region 2 of the CYP27B1 promoter, which contains the characterized nVDRE, supports this down-regulation but also region 9 (in which VDRE2 resides).
Ligand-dependent association of cofactor proteins with CYP27B1 promoter regions
To further characterize the role of the CYP27B1 gene promoter regions 2, 7 and 9, we performed an extensive ChIP analysis with antibodies against multiple VDR partner proteins in HEK-293 and MCF-7 cells ( Figure 5 ). Region 6 of the CYP27B1 promoter, which does not contain a VDRE, served as a negative control and a region covering the proximal promoter of the CYP24 gene including its VDRE cluster was the positive control. In addition to VDR and RXR, the proteins were chosen to represent general chromatin activity (AcH3 and AcH4), gene activation (the CoAs SRC-1, SRC-2, SRC-3, CBP and pPolII) and gene repression (Sin3A and the CoRs SMRT and NCoR). At the three VDRE-containing regions of the CYP27B1 promoter and in both cell types the acetylation level of histone H3 decreased in response to 1a,25(OH) 2 D 3 treatment, while on the proximal promoter of the CYP24 gene it significantly increased. However, at all four VDRE-containing regions the histone H4 acetylation level increased after ligand treatment.
In both cell types, VDR and RXR were associated ligand-dependently with the three VDRE-containing regions and the CYP24 region, but not with the negative control region 6. The recruitment of HAT CBP, whose main substrate is the histone H3 tail, mirrored the changes in the histone H3 acetylation levels with the exception of the proximal promoter of the CYP24 gene in HEK-293 cells, which did not bind CBP. In both cell types, pPolII associated strongly with the region 2 (containing the nVDRE) and reduced its binding after ligand treatment. Interestingly, in HEK-293 cells the same observation was made with region 7 (containing VDRE1), while in MCF-7 cells pPolII remained associated with the region even after ligand treatment. In both cell lines, region 9 and the negative control did not show any binding of PolII, while the proximal promoter of the CYP24 gene demonstrated strong ligand-dependent recruitment of the polymerase.
The association of CoAs of the p160 family with different regions significantly differed in HEK-293 and MCF-7 cells. After ligand treatment in MCF-7 cells, SRC-1, SRC-2 and SRC-3 were recruited to the proximal CYP24 promoter, while in HEK-293 cells this was the case only for SRC-1 and SRC-3. In HEK-293 cells, SRC-1 and SRC-3 bound only to region 2 of the CYP27B1 promoter (and not to regions 6, 7 and 9) and dissociated from it after ligand stimulation. In contrast, in MCF-7 cells, SRC-1 bound constitutively to regions 2 and 7 (and not to region 9), while SRC-3 was strongly recruited by ligand treatment to regions 7 and 9 and in parallel partially dissociated from region 2.
In both cell lines, Sin3A bound constantly to region 2 through the time points analyzed and in HEK-293 cells, also to regions 7 and 9. After ligand stimulation, Sin3A dissociated in both cell lines from the proximal promoter fragment of the CYP24 gene, while in parallel, in MCF-7 S-labeled proteins that were analyzed on a 12% denaturing polyacrylamide gel (B). Gel shift experiments were performed with in vitro-translated VDR, RXR and VDIR proteins in the presence or absence of 1 mM 1a,25(OH) 2 D 3 on the established DR4-type VDRE of the rat pit-1 gene (core sequence 5 0 -gaAGTTCAtgagAGTTCA-3 0 , C), the nVDRE (D) and the putative VDREs 1, 2 and 3 (E-G). Anti-VDR antibody was used to challenge the specificity of the protein-DNA complexes. The latter were resolved from free probe through 8% non-denaturing polyacrylamide gels. Representative gels are shown. cells, it was recruited to region 7 and not at all to region 9. The CoR, SMRT was recruited by ligand in both cell lines to regions 2 and 7 and dissociated from the proximal CYP24 promoter region. SMRT was in HEK-293 cells and was also recruited to region 9, a phenomenon not observed in MCF-7-cell-derived chromatin templates. Finally, in HEK-293 cells, after ligand treatment, NCoR1 was recruited to regions 2, 7 and 9, while in MCF-7 cells it was only recruited to region 7 and in parallel dissociated from regions 2 and 9. In both cell lines, NCoR1 dissociated from the proximal CYP24 promoter.
Taken together, the ligand-dependent association and dissociation of cofactor proteins to the three VDRbinding regions of the CYP27B1 promoter, in particular the CoAs SRC-1 and SRC-3 and the CoR, NCoR1, show significant differences between HEK-293 and MCF-7 cells. Figure 4 . Functional analysis of the VDR-associated regions in the CYP27B1 promoter. Regions 2, 7 and 9 of the human CYP27B1 promoter were cloned alone or together (as found in the human genome) in front of thymidine kinase (tk) promoter driving the luciferase (Luc) gene. The proximal promoter of the human CYP24 gene containing a cluster of DR3-type VDREs was used as a positive control and the empty reporter vector as a negative control. These reporter gene constructs were transfected together with an expression vector for VDR to HEK-293 (A) and MCF-7 (B) cells. Luciferase activity was determined after 16 h 1a,25(OH) 2 D 3 treatment. Columns indicate the means of three independent experiments and the tips of the bars represent standard deviations. Two-tailed, paired Student's t-tests were performed and P-values ( ÃÃÃ P50.001) of the fold inductions were calculated in reference to vehicle-treated controls.
This may explain the differential transcriptional response of the CYP27B1 gene in both cell lines to stimulation with 1a,25(OH) 2 D 3 .
Connectivity of the distal and proximal VDR-binding regions of the CYP27B1 promoter
We used 3C assays in order to investigate, whether the distal regions 7 and 9 of the human CYP27B1 promoter are directly connected with region 2 containing the nVDRE and/or region 1 including the TSS (Figure 6 ). The restriction enzyme HinfI was used to digest major parts of the DNA loops between the binding sites of genomic primers on the TSS (A), a control site (B), VDRE1 (C) and VDRE2/3. Under no conditions was a PCR product obtained with the genomic primers A and B, indicating that the control region was not looping to the In summary, the 3C analysis indicated that in HEK-293 cells DNA looping between regions 1/2 and regions 7 and 9 takes place suggesting that the VDREs in these regions may act synergistically. Moreover, in HEK293 cells specifically, region 9 interacted with regions 1/2 only in the presence of hormone. This together with our previous reporter gene analysis indicates that region 9 contains a functional vitamin D-dependent repressor that is able to act together with the TSS/nVDRE-containing region to repress gene transcription. In contrast, in MCF-7 cells only a connection between regions 1/2 and region 7 was observed and this did not lead to gene repression.
DISCUSSION
The mechanism of negative gene regulation by nuclear receptors is still poorly understood, but the human CYP27B1 gene and its down-regulation in the presence of 1a,25(OH) 2 D 3 may be so far the most detailed model (4) . Since the model takes account only the proximal promoter of the CYP27B1 gene, we aimed in this study to test the hypothesis that also in the case of gene repression multiple response elements located in more distal regions may be involved in the regulation.
The distance between the TSSs of the neighboring genes CYP27B1 and METTL1 is only 5.4 kb (Figure 2A) , with the METTL1 gene being read in the same direction as CYP27B1 (its last exon ends only 1.2 kb upstream of the TSS of the CYP27B1gene). Thus, the promoter of CYP27B1 seems to be only 1.2 kb in size. Indeed, the studies of human and mouse CYP27B1 promoters have so far considered only the first 1.7 kb upstream from the TSS of CYP27B1 (4, (27) (28) (29) . Therefore, it is interesting that the combined results of our in silico screening and promoter ChIP scanning suggested that within the studied CYP27B1 promoter region, two additional VDREs, located in regions 7 and 9 (being within introns of the METTL1 gene) upstream from region 2 carrying the nVDRE. According to our ChIP scanning of the CYP27B1 promoter, the time-dependent binding profile of VDR was similar both in MCF-7 cells and HEK-293 cells with one exception. In HEK-293 cells, the VDR seemed to associate with the described CYP27B1 gene TSS stronger than in MCF-7 cells (Figure 2 ). Since region 1 possesses neither an nVDRE nor a regular VDRE, this may suggest that the protein bridge exists between the VDR-binding regions and the TSS in HEK-293, but not in MCF-7 cells.
According to Murayama and colleagues (4) , the association of the VDR-RXR heterodimer to the nVDRE is not a direct binding to DNA, but occurs via the transcription factor VDIR. We found that in vitrotranslated VDR-RXR heterodimers cannot bind to the nVDRE although in vitro-translated VDIR can (Figure 3 ). Interestingly, with the distal VDREs, reasonable VDR-RXR heterodimer association could be observed with VDRE1 and VDRE2 from regions 7 and 9, respectively. This did not apply to the neighboring VDRE3, suggesting that VDR is associated only with VDRE2 within region 9. The binding of the VDR-RXR complex to VDRE1 and VDRE2 was ligand dependent, but contrary to that of nVDRE, the binding may involve direct interactions with DNA sequences. Therefore, the new distal VDREs resemble positive VDREs, as has been previously described for most of the negative VDREs identified so far (10) (11) (12) .
A reporter gene analysis of different CYP27B1 promoter fragments (Figure 4) showed that both the regions containing the nVDRE and VDRE2/3 were able to repress gene activity in HEK-293 cells, but not in MCF-7 cells. In addition, a longer promoter fragment including both the nVDRE and VDRE2/3, an even more significant repression was achieved. Therefore, our results suggest that both nVDRE and VDRE2/3 are efficient negative regulators of the CYP27B1 promoter and work in HEK-293 cells together in the repression of CYP27B1 gene expression.
Our ChIP data suggested that the acetylation level of histone H3 tails was decreased in both cells in response to 1a,25(OH) 2 D 3 ( Figure 5 ). Interestingly, although the histone H3 acetylation levels decreased, the chromatin did not change to completely non-permissive form, because the acetylation status of the histone H4 at all regions remained constant or even increased after the addition of 1a,25(OH) 2 D 3 . The acetylation level of histone H3 at control region remained constantly high and acetylation level of histone H4 increased. This suggests that a wide area of chromatin of distal CYP27B1 promoter is permissive in both cells in the absence of ligand, which may be related to the high basal activity of CYP27B1 gene. Addition of ligand results in local deacetylation of regions 7 and 9 together with region 2 thus leading to repression. Neither of these histone acetylation patterns is able to describe the cell-typeselective repression described here. However, it is possible that other forms of histone marking such as methylation, acting alone or in combination with the histone acetylation may be involved. It is also possible that tissueselective factors may have to be present.
In both cell types, different transcription factors were associated with the nVDRE in a very similar fashion ( Figure 5 ). Significant differences could be observed in the recruitment of pPolII, the CoAs SRC-1 and SRC-3 and the CoR NCoR. In MCF-7 cells, the VDRE1-containing region seemed to favor interactions with CoAs more than in HEK-293 cells. Contrary to this, the region containing This hypothesis is supported by the fact that our 3C analysis confirmed that the proximal and distal regions of the human CYP27B1 gene promoter are in contact with each other (Figure 6 ). From the results, it can be observed that in MCF-7 cells region 7 (containing VDRE1) is connected to the region containing the TSS in a liganddependent manner, but the region containing VDRE2/3 does not form any similar connections. In contrast to this, in HEK-293 cells, regions encompassing both VDRE1 and VDRE2/3 were connected with a region containing the TSS of the CYP27B1 gene. The connection between the VDRE1-containing region and the proximal promoter was present both in the absence and in the presence of ligand. However, the most striking result was that VDRE2/3-containing region was only in contact with the proximal promoter when 1a,25(OH) 2 D 3 was present.
This suggests that VDRE1-containing region seems to be related more with basal (positive) transcriptional activity and that the VDRE2/3-containing region may have an important role in transcriptional repression. Please note that because there were no restriction-enzyme-cutting sites between the nVDRE and the TSS, it was impossible to determine exactly if VDRE1 or VDRE2/3 are connected to the nVDRE or TSS or both. In this case, the 3C analysis only reveals that the distal regions are connected with the proximal region that contains both the nVDRE and TSS.
In the light of our results presented here, we propose a model that may explain the role of distal VDREs in the transcriptional regulation of CYP27B1 gene in HEK-293 cells (Figure 7 ). When the gene is active, chromatin looping brings the distal region, which includes VDRE1, close to the proximal promoter. Both regions associate with a common super complex of transcription factors that is broadly transcriptionally positive and includes CoAs such as SRC-1, SRC-2, SRC-3 and CBP. The nVDRE is connected via VDIR, but the anchoring transcription factor at VDRE1 is presently unknown. We cannot either exclude the possibility that the ligandindependent looping happens via some other element that locates close to VDRE1. The HAT activity of CBP acetylates the histone H3 tails and thus keeps the chromatin at proximal promoter permissive for basal transcriptional machinery including pPolII. The region containing VDRE2/3 on the other hand is not involved in the transcriptional activation of the CYP27B1 gene as can be inferred from its non-connectedness to the TSScontaining region in MCF-7 cells. However, it seems to recruit several transcription factors including repressive proteins, which are missing from the super complex associated with the nVDRE-and VDRE1-containing chromatin regions, selectively in HEK-293 cells. This suggests that a different complex is bound to this region, but the purpose of this complex is presently unknown as well as how the protein complex is associated with the region containing VDRE2/3. The addition of 1a,25(OH) 2 D 3 results in the modulation of the super complex where activating transcription factors are replaced with repressing proteins. At the same time, the chromatin architecture changes and chromatin looping locates VDRE2/3 close to proximal promoter allowing it to associate with a common repressive super complex together with nVDRE and VDRE1.
In conclusion, we have revealed that the responsiveness of the CYP27B1 gene to 1a,25(OH) 2 D 3 is a cell-typeselective event that involves different combinations of multiple VDREs that act to recruit and interact with protein super complexes of differing transcriptional abilities. It is hoped that this work will allow us to understand better gene repression by nuclear receptors in general and the tissue-selective nature of the CYP27B1 gene repression by 1a,25(OH) 2 D 3 specifically.
